Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study Comparing Chloroprocaine Gel and Oxybuprocaine Drops for Eye Anesthesia in Children Needing Eye Exams
ItalyStudy on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
ItalyStudy of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ItalyStudy on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease
ItalyStudy on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery
ItalyStudy Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Treatment
ItalyStudy Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer
ItalyStudy on the Safety and Tolerability of Higher Dose Rifampicin for Tuberculosis Patients
ItalyStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination
ItalyStudy on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis
ItalyStudy of Disitamab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer Expressing HER2
ItalyStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
